HM13 is a predictive biomarker of metastasis and neutrophil infiltration in colorectal cancer.
The results suggested that high HM13 expression in CRC could promote tumor growth and metastasis by reducing neutrophil infiltration and may serve as a useful target in the treatment of metastatic CRC.
Authors
- Yunqing Ren (ORCID: https://orcid.org/0000-0002-9799-8625)
- Xiao Yuan (ORCID: https://orcid.org/0000-0003-0684-0070)
- Ying Mao
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-09-01
- DOI
- https://doi.org/10.14670/hh-18-857
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00